Stefan K. Barta, MD, MS

faculty photo
Associate Professor of Clinical Medicine (Hematology-Oncology)
Department: Medicine

Contact information
Perelman Center
12th Floor, Room 12-177
3400 Civic Center Blvd
Philadelphia, PA 19104
Office: 2156156506
Fax: 2156155887
Education:
MD (Medicine)
Johann-Wolfgang Goethe University , 1999.
MS (Clinical Research Methods)
Albert Einstein College of Medicine , 2011.
Permanent link
 
> Perelman School of Medicine   > Faculty   > Details

Description of Clinical Expertise

T-cell lymphomas; HIV-associated lymphomas; Cutaneous lymphomas

Description of Research Expertise

HIV related lymphomas; T-cell lymphomas; Cutaneous lymphomas.

Selected Publications

Epperla N, Zhao Q, Moyo T, Watkins MP, Tavakkoli M, Bello C, Torka P, Reddy N, Thomas C, Annunzio K, Christian B, Barta SK, Shouse G, Olszewski AJ, Bartlett NL.: Outcomes of marginal zone lymphoma treated with ibrutinib in the first-line setting in USA: A Real World Analysis. Blood Adv Dec 2023.

Landsburg DJ, Morrissette JJ, Nasta SD, Barta SK, Schuster SJ, Svoboda J, Chong EA, Bagg A.: TP53 mutations predict for poor outcomes in patients with newly diagnosed aggressive B-cell lymphomas in the current era. Blood Adv 7: 7243-7253, Dec 2023.

Gerson JN, Handorf E, Villa D, Gerrie AS, Chapani P, Li S, Medeiros LJ, Wang M, Cohen JB, Churnetski M, Hill BT, Sawalha Y, Hernandez-Ilizaliturri FJ, Kothari S, Vose JM, Bast M, Fenske T, Rao Gari SN, Maddocks KJ, Bond D, Bachanova V, Kolla B, Chavez J, Shah B, Lansigan F, Burns T, Donovan AM, Wagner-Johnston N, Messmer M, Mehta A, Anderson JK, Reddy N, Kovach AE, Landsburg DJ, Glenn M, Inwards DJ, Ristow K, Karmali R, Kaplan JB, Caimi PF, Rajguru S, Evens A, Klein A, Umyarova E, Pulluri B, Amengual JE, Lue JK, Diefenbach C, Fisher RI, Barta SK.: Outcomes of patients with blastoid and pleomorphic variant mantle cell lymphoma. Blood Adv 7: 7393-7401, Dec 2023.

Iyer SP, Johnston PB, Barta SK.: Pralatrexate Injection Combined with CHOP for Treatment of PTCL-Results from the Fol-CHOP Dose-Finding Phase 1 Trial. Blood Adv Nov 2023.

Annunzio K, Grover NS, Welkie RL, Torka P, Watkins MP, Anampa-Guzmán A, Tavakkoli M, Oh TS, Reves H, Jones D, Hanel W, Christian B, Ramakrishnan Geethakumari P, Karmali R, Barta SK, Bartlett NL, Olszewski AJ, Epperla N.: Impact of circulating lymphoma cells at diagnosis on outcomes in patients with marginal zone lymphoma: a multicenter cohort study. Blood Adv 7: 6839-6843, Nov 2023.

Epperla N, Feng L, Shah NN, Fitzgerald L, Shah H, Stephens DM, Lee CJ, Ollila T, Shouse G, Danilov AV, David KA, Torka P, Hashmi H, Hess B, Barta SK, Romancik JT, Cohen JB, Annunzio K, Kittai AS, Reneau J, Zurko J, Nizamuddin IA, Winter JN, Gordon LI, Ma S, Patel R, Nastoupil L, Ahmed S, Karmali R.: Outcomes of patients with secondary central nervous system lymphoma following CAR T-cell therapy: a multicenter cohort study. J Hematol Oncol 16: 111, Nov 2023.

Barta SK, Liu N, DerSarkissian M, Chang R, Ye M, Duh MS, Surinach A, Fanale M, Yu KS.: Real-World Treatment Patterns and Clinical Outcomes With Brentuximab Vedotin or Other Standard Therapies in Patients With Previously Treated Cutaneous T-Cell Lymphoma in the United States. Clin Lymphoma Myeloma Leuk Oct 2023.

Angelos MG, Patel RP, Ruella M, Barta SK.: Progress and Pitfalls of Chimeric Antigen Receptor T Cell Immunotherapy against T Cell Malignancies. Transplant Cell Ther Oct 2023.

Epperla N, Zhao Q, Karmali R, Torka P, Shea L, Oh TS, Anampa-Guzmán A, Reves H, Tavakkoli M, Greenwell IB, Hansinger E, Umyarova E, Annunzio K, Sawalha Y, Christian B, Thomas C, Barta SK, Geethakumari PR, Bartlett NL, Grover NS, Olszewski AJ.: Impact of detectable monoclonal protein at diagnosis on outcomes in marginal zone lymphoma: a multicenter cohort study. Blood Adv 7: 5038-5046, Sep 2023.

Tavakkoli M, Barta SK.: 2024 Update: Advances in the risk stratification and management of large B-cell lymphoma. Am J Hematol Aug 2023.

back to top
Last updated: 12/18/2023
The Trustees of the University of Pennsylvania